Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A

Jiro Kida1,2, Kiyotaka Nemoto3, Chiaki Ikejima4

  • 1Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan.

Abstract

Insights

Amnestic mild cognitive impairment (aMCI) significantly increases Alzheimer's disease risk. Depressive symptoms exacerbate this risk in aMCI, but not in nonamnestic MCI (naMCI).

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychiatry

Background:

  • Longitudinal studies on mild cognitive impairment (MCI) subtypes and dementia subtypes yield contradictory results.
  • Comorbid depressive symptoms with MCI may elevate the risk for Alzheimer's disease (AD).

Purpose of the Study:

  • To longitudinally investigate the relationships between MCI subtypes and dementia subtypes.
  • To specifically examine the effect of comorbid depressive symptoms on these relationships in a Japanese rural community.

Main Methods:

  • A cohort of 802 non-demented participants underwent baseline and follow-up assessments.
  • Complementary log-log analysis assessed the risk of dementia and AD conversion in amnestic MCI (aMCI) versus nonamnestic MCI (naMCI) groups.
  • The impact of depressive symptoms on transitions from MCI to AD and from cognitive normality to MCI or AD was analyzed.

Main Results:

  • The aMCI group exhibited a significantly higher risk of developing dementia, particularly AD, compared to the naMCI group.
  • In the aMCI group, depressive symptoms increased AD risk; this effect was not observed in the naMCI group.
  • In cognitively normal individuals, depressive symptoms elevated the risk of developing aMCI, but not naMCI or AD.

Conclusions:

  • MCI subtyping, distinguishing between amnestic and nonamnestic forms, is valuable for identifying dementia and AD prodromes.
  • The differential impact of depressive symptoms suggests distinct relationships between depression and cognitive impairment in aMCI versus naMCI.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
971
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
676
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.1K
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K